Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with a medical condition:
- You must be able to read and sign a consent form agreeing to take part
- You must have been on stable preventive medication for at least 2 months before your MRI scan
- You have been diagnosed with migraine (with or without aura, occurring occasionally or frequently) with at least 2 migraine attacks per month, confirmed by a doctor's interview and questionnaire at least 8 weeks before your MRI
- OR you have epilepsy that has not responded to medication, based on recognised medical guidelines (confirm with trial site)
- OR you have been diagnosed with Visual Snow Syndrome
For healthy volunteers:
- You do not have migraine or epilepsy (confirmed by questionnaire)
- You must be able to read and sign a consent form agreeing to take part
Who may not be able to join:
- You have received Botox treatment for migraine within the last 4 months or plan to during the study
- You are currently pregnant or breastfeeding
- You plan to become pregnant during the trial
- You have other serious health conditions such as kidney, liver, or heart problems
- You are known or suspected to not follow the study rules, or have issues with drug or alcohol use
- You are unable to follow the trial procedures due to language barriers, mental illness, or dementia
- You have previously taken part in this clinical trial
- You are the investigator, or a family member or employee of the research team
- You have metal objects inside your body that are not compatible with MRI scans (e.g., certain implants or metal fragments)
- You have a pacemaker
- You experience claustrophobia (fear of enclosed spaces)
- Your Body Mass Index (BMI) is above 35 (confirm with trial site if unsure of your BMI)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patrick Freund, Prof. Dr. med. Dr. rer. nat., University of Zurich
Phone: +41 44 510 72 08
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MR: multi-parameter mapping (MPM); MR: quantitative susceptibility mapping (QSM); Resting-state fMRI (brain and brainstem/spinal cord); MR: whole-brain structural scans; MR: routine clinical scans; MR spectrosocpy; MR: diffusion imaging; MR: axial T2*w sequence; Task-fMRI
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.